AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.07%166.350.7%$1322.99m
LLYEli Lilly & Co. -0.29%333.201.1%$1039.75m
PFEPfizer Inc. -0.28%44.270.9%$799.00m
BMYBristol-Myers Squibb Co. 0.00%72.061.0%$784.71m
ABBVAbbVie, Inc. -0.58%143.721.9%$777.17m
MRKMerck & Co., Inc. -0.82%86.080.7%$697.20m
AZNAstraZeneca Plc -0.70%54.311.0%$434.02m
NVSNovartis AG -1.43%75.220.2%$218.10m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%210.768.2%$210.83m
GSKGSK Plc -0.76%29.230.3%$204.46m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.115.4%$190.67m
NVONovo Nordisk A/S 1.29%100.660.1%$177.86m
HZNPHorizon Therapeutics Plc -0.55%63.495.4%$169.03m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.42%151.310.0%$157.49m
SGENSeagen Inc. 0.00%137.725.7%$129.81m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.